Literature DB >> 34422098

Calorie provision from citrate anticoagulation in continuous renal replacement therapy in critical care.

Alice R Rogers1, Bethan Jenkins1.   

Abstract

BACKGROUND: Citrate is used as a regional anticoagulant for continuous veno-venous haemofiltration and provides 0.59 kcal/mmol. Previous studies hypothesised continuous veno-venous haemofiltration can provide 200-1300 kcal/day dependent on the anticoagulant and replacement solutions used. The aim of this study was to calculate the calorie load from citrate in our patient group.
METHODS: An equation derived from a paper by Oudemans-van Straaten was used to estimate calorie provision from citrate. Citrate calorie load was defined as the difference between the citrate in the filter circuit and the removal by continuous veno-venous haemofiltration. Clinical data were recorded on 20 consecutive patients admitted to intensive care unit and commenced on citrate continuous veno-venous haemofiltration using prismacitrate 18/0 by Gambro, a tri-sodium citrate solution. Clinical data recorded included patient demographics, filter settings including blood flow, filtration factor, citrate dose and time on filtration daily.
RESULTS: A total of 20 critically ill patients received continuous veno-venous haemofiltration for treatment of a new acute kidney injury, mean age 66 years, 65% male. Mean duration of continuous veno-venous haemofiltration was 3.7 days. Mean daily time on filtration was 20 h/day. Mean filtration fraction, citrate dose and blood flow were 30%, 3 mmol/L and 123 ml/min, respectively. Our calculation showed that a mean of 9.5 ± 1.7 cal/h were provided from citrate with a mean daily calorie load of 196 ± 69 kcal.
CONCLUSIONS: Continuous veno-venous haemofiltration with tri-sodium citrate provided an additional 196 ± 69 kcal/day. The calorie load from citrate continuous veno-venous haemofiltration should be calculated regularly as changes in filter settings, in particular citrate dose and blood flow can have a significant impact on calorie provision. © The Intensive Care Society 2020.

Entities:  

Keywords:  Citrate; calorie; critical illness; renal replacement therapy

Year:  2020        PMID: 34422098      PMCID: PMC8373286          DOI: 10.1177/1751143720937451

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  14 in total

1.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.

Authors:  Eric A J Hoste; Sean M Bagshaw; Rinaldo Bellomo; Cynthia M Cely; Roos Colman; Dinna N Cruz; Kyriakos Edipidis; Lui G Forni; Charles D Gomersall; Deepak Govil; Patrick M Honoré; Olivier Joannes-Boyau; Michael Joannidis; Anna-Maija Korhonen; Athina Lavrentieva; Ravindra L Mehta; Paul Palevsky; Eric Roessler; Claudio Ronco; Shigehiko Uchino; Jorge A Vazquez; Erick Vidal Andrade; Steve Webb; John A Kellum
Journal:  Intensive Care Med       Date:  2015-07-11       Impact factor: 17.440

Review 2.  Specialized nutritional support interventions in critically ill patients on renal replacement therapy.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Umberto Maggiore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-03       Impact factor: 4.294

3.  A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients.

Authors:  Sean M Bagshaw; Carol George; Rinaldo Bellomo
Journal:  Nephrol Dial Transplant       Date:  2008-02-15       Impact factor: 5.992

Review 4.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

5.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience.

Authors:  Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Brandon R Savage; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Glenn M Chertow
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

Review 6.  Parenteral nutrition in the critically ill patient.

Authors:  Thomas R Ziegler
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

7.  Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.

Authors:  Martin Balik; Mykhaylo Zakharchenko; Pavel Leden; Michal Otahal; Jan Hruby; Ferdinand Polak; Katerina Rusinova; Zdenek Stach; Monika Tokarik; Jaroslava Vavrova; Antonin Jabor; Heleen M Oudemans-van Straaten
Journal:  J Crit Care       Date:  2012-08-27       Impact factor: 3.425

8.  Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study.

Authors:  Oren Zusman; Miriam Theilla; Jonathan Cohen; Ilya Kagan; Itai Bendavid; Pierre Singer
Journal:  Crit Care       Date:  2016-11-10       Impact factor: 9.097

Review 9.  Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria.

Authors:  J Koeze; F Keus; W Dieperink; I C C van der Horst; J G Zijlstra; M van Meurs
Journal:  BMC Nephrol       Date:  2017-02-20       Impact factor: 2.388

10.  Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients.

Authors:  Peter J M Weijs; Wilhelmus G P M Looijaard; Albertus Beishuizen; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2014-12-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.